GREENLAND MINES LTD Deferred Tax Assets, Tax Deferred Expense, Other
GREENLAND MINES LTD (GRML) had Deferred Tax Assets, Tax Deferred Expense, Other of $308.26 thousand as of 2023-12-31, per its 10-K filed 2024-04-17.
Discontinued › Notes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther · last filed 2024-04-17
- 2023-12-31: Deferred Tax Assets, Tax Deferred Expense, Other $308.26K.
- 2022-12-31: Deferred Tax Assets, Tax Deferred Expense, Other $112.14K.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Other |
|---|---|
| 2023-12-31 | $308.26K 10-K · filed 2024-04-17 |
| 2022-12-31 | $112.14K 10-K · filed 2024-04-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |